Lee D Cranmer

  • 2813 Citations
  • 25 h-Index
1991 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Melanoma Medicine & Life Sciences
Sarcoma Medicine & Life Sciences
Muromegalovirus Medicine & Life Sciences
Skin Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2018

  • 2813 Citations
  • 25 h-Index
  • 59 Article
  • 1 Review article

A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma

Clark, J. I., Singh, J., Ernstoff, M. S., Lao, C. D., Flaherty, L. E., Logan, T. F., Curti, B., Agarwala, S. S., Taback, B., Cranmer, L., Lutzky, J., Luna, T. L., Aung, S. & Lawson, D. H., Jul 27 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 76

Research output: Contribution to journalArticle

Interleukin-2
Melanoma
Mutation
Antigen Presentation
Neoplasm Antigens

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

Zager, J. S. , Gastman, B. R. , Leachman, S. , Gonzalez, R. C. , Fleming, M. D. , Ferris, L. K. , Ho, J. , Miller, A. R. , Cook, R. W. , Covington, K. R. , Meldi-Plasseraud, K. , Middlebrook, B. , Kaminester, L. H. , Greisinger, A. , Estrada, S. I. , Pariser, D. M. , Cranmer, L. D. , Messina, J. L. , Vetto, J. T. , Wayne, J. D. & 3 others Delman, K. A., Lawson, D. H. & Gerami, P., Feb 5 2018, In : BMC Cancer. 18, 1, 130

Research output: Contribution to journalArticle

Transcriptome
Melanoma
Skin
Neoplasm Metastasis
Recurrence

16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria

Watts, G. S., Youens-Clark, K., Slepian, M. J., Wolk, D. M., Oshiro, M. M., Metzger, G. S., Dhingra, D., Cranmer, L. D. & Hurwitz, B. L., Dec 1 2017, In : Journal of Applied Microbiology. 123, 6, p. 1584-1596 13 p.

Research output: Contribution to journalArticle

rRNA Genes
Bacteria
Ions
Databases
Metagenomics
5 Citations

Angiosarcoma treated successfully with anti-PD-1 therapy - a case report

Sindhu, S., Gimber, L. H., Cranmer, L., McBride, A. & Kraft, A. S., Jul 18 2017, In : Journal for ImmunoTherapy of Cancer. 5, 1, 58

Research output: Contribution to journalArticle

Hemangiosarcoma
Sarcoma
Immunotherapy
Programmed Cell Death 1 Receptor
Neoplasms
17 Citations

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

Tap, W. D. , Papai, Z. , Van Tine, B. A. , Attia, S. , Ganjoo, K. N. , Jones, R. L. , Schuetze, S. , Reed, D. , Chawla, S. P. , Riedel, R. F. , Krarup-Hansen, A. , Toulmonde, M. , Ray-Coquard, I. , Hohenberger, P. , Grignani, G. , Cranmer, L. D. , Okuno, S. , Agulnik, M. , Read, W. , Ryan, C. W. & 8 others Alcindor, T., del Muro, X. F. G., Budd, G. T., Tawbi, H., Pearce, T., Kroll, S., Reinke, D. K. & Schöffski, P., Aug 1 2017, In : The Lancet Oncology. 18, 8, p. 1089-1103 15 p.

Research output: Contribution to journalArticle

Sarcoma
Doxorubicin
Survival
TH 302
Therapeutics